Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integr…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices. | ||
 Outset Medical (OM) Q2 2026 Earnings Call Transcript CEO highlights $40M HCA refresh deal as first major console fleet win. | ||
 Outset Medical Q2 Earnings Call Highlights Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of | ||
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ... Outset Medical Inc (OM) reports Q2 2026 revenue of $31.6 million, up 14% sequentially, with a significant gross margin improvement and a $40 million HCA refresh agreement extending through 2028. | ||
 Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates Outset Medical (OM) delivered earnings and revenue surprises of -26.98% and +9.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||